Light-activated photodynamic compounds from Theralase destroy E. coli bacteria

Sept. 15, 2011
Toronto, ON, Canada--Theralase Technologies' Photo Dynamic Compounds can destroy Escherichia coli, commonly known as the disease-causing bacteria E. coli.

Toronto, ON, Canada--After its announcement late last year that its photodynamic compounds work with light to destroy listeria bacteria, Theralase Technologies just reported that those compounds can also destroyEscherichia coli, commonly known as E. coli, a widely prevalent disease causing bacteria. Theralase, who designs, develops, manufactures, and markets patented superpulsed laser technology utilized in biostimulation and biodestruction applications, says its patented Photo Dynamic Compounds (PDCs) can be activated with light to destroy a host of harmful bacteria in clinical settings.

E. coli is one of the top four pathogens causing Healthcare Associated Infections (HAIs), and the U.S. Centers for Disease Control and Prevention estimates that HAIs have led to $45 billion in healthcare costs annually and have resulted in nearly 100,000 deaths per year, making HAIs the fourth leading cause of death.

Arkady Mandel, chief scientific officer at Theralase, said, "Our research has repeatedly demonstrated that our Photo Dynamic Therapy (PDT) destruction of E. coli bacteria is effective and represents a significant opportunity in the area of disinfection and sterilization of bacterial pathogens that may cause serious and potentially life-threatening illness."

Roger Dumoulin-White, president and CEO of Theralase, added, "We are encouraged that our patented Photo Dynamic Compounds (PDCs) are proving effective in so many varied applications. Not only are these PDCs being shown to be effective in the destruction of cancer cells, but now they are also being shown to be effective in the destruction of various types of bacteria, including Listeria and E. coli. Commercialization of these technologies becomes more and more apparent, as our research and development progresses, allowing us the opportunity to introduce these technologies to the world in a variety of diverse applications."

SOURCE: Theralase; www.theralase.com/press/Theralase_Achieves_Success_in_Destruction_of_E__Coli_4.pdf

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on Twitter Follow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

How Precision Motion Systems are Shaping the Future of Semiconductor Manufacturing

March 28, 2024
This article highlights the pivotal role precision motion systems play in supporting the latest semiconductor manufacturing trends.

Understanding 3D Printing Tolerances: A Guide to Achieving Precision in Additive Manufacturing

March 28, 2024
In the world of additive manufacturing, precision is paramount. One crucial aspect of ensuring precision in 3D printing is understanding tolerances. In this article, we’ll explore...

Automation Technologies to Scale PIC Testing from Lab to Fab

March 28, 2024
This webinar will cover the basics of precision motion systems for PIC testing and discuss the ways motion solutions can be specifically designed to address the production-scale...

Case Study: Medical Tube Laser Processing

March 28, 2024
To enhance their cardiovascular stent’s precision, optimize throughput and elevate part quality, a renowned manufacturer of medical products embarked on a mission to fabricate...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!